Mankind Pharma posted a 9.5 per cent rise in Q3FY26 net profit and 11.5 per cent growth in revenue, driven by strong domestic demand for chronic therapies
Source :- Companies Read More
Mankind Pharma Q3 PAT up 9.5%, revenue rises 11.5% on chronic sales
- No Comments
- 6 Min Read
Share it :
Get free tips and resources right in your inbox, along with 10,000+ others
Categories
Latest Post
August 24, 2026
